Načítá se...
The utility of phospholipase A2 receptor autoantibody in membranous nephropathy after kidney transplantation
Membranous nephropathy (MN) is estimated to cause end-stage renal disease in ∼ 5% of patients, in whom renal transplantation is the therapy of choice. Among patients receiving a transplant for MN, the disease will recur in the graft in 30–50%; among these, graft loss will occur in 50% within 10 year...
Uloženo v:
| Vydáno v: | Clin Kidney J |
|---|---|
| Hlavní autoři: | , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6007417/ https://ncbi.nlm.nih.gov/pubmed/29988247 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ckj/sfx128 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|